ODEVIXIBAT EFFECTS ON CHOLESTASIS-RELATED PARAMETERS: ANALYSIS OF POOLED DATA FROM THE PEDFIC 1 AND PEDFIC 2 STUDIES IN CHILDREN WITH PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS

被引：0
|
作者：
Thompson, Richard J.
Artan, Reha
Baumann, Ulrich
Czubkowski, Piotr
Dalgic, Buket
Durmaz, Ozlem
Gonzales, Emmanuel
Grammatikopoulos, Tassos
Gupte, Girish
Horn, Patrick
Lachaux, Alain
Mckiernan, Patrick
Ozen, Hasan
Rajwal, Sanjay R.
Roquelaure, Bertrand
Sturm, Ekkehard
Verkade, Henkjan J.
Yu, Qifeng
Kjems, Lise
机构：
来源：
GASTROENTEROLOGY | 2022年 / 162卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
EP1232
引用
收藏
页码：S1296 / S1297
页数：2
相关论文
共 34 条
  • [1] Odevixibat effects on cholestasis-related parameters: Analysis of pooled data from the PEDFIC 1 and PEDFIC 2 studies in children with progressive familial intrahepatic cholestasis
    Thompson, Richard
    Artan, Reha
    Baumann, Ulrich
    Czubkowski, Piotr
    Dalgic, Buket
    Durmaz, Ozlem
    Gonzales, Emmanuel
    Grammatikopoulos, Tassos
    Gupte, Girish
    Horn, Patrick
    Lachaux, Alain
    McKiernan, Patrick
    Ozen, Hasan
    Rajwal, Sanjay
    Roquelaure, Bertrand
    Sturm, Ekkehard
    Verkade, Henkjan
    Yu, Qifeng
    Kjems, Lise
    [J]. JOURNAL OF HEPATOLOGY, 2021, 75 : S687 - S687
  • [2] HEPATIC PARAMETERS, GROWTH, AND SLEEP WITH RESPONDERS AND NONRESPONDERS TO ODEVIXIBAT TREATMENT: POOLED DATA FROM THE PEDFIC 1 AND PEDFIC 2 STUDIES IN CHILDREN WITH PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS
    McKiernan, Patrick James
    Sturm, Ekkehard
    Kamath, Binita
    Thompson, Richard J.
    Gonzales, Emmanuel M.
    Lachaux, Alain
    Baumann, Ulrich
    Shteyer, Eyal
    Czubkowski, Piotr
    Artan, Reha
    Dalgic, Buket
    Ozen, Hasan
    Gupte, Girish
    Grammatikopoulos, Tassos
    Karpen, Saul J.
    Ni, Quanhong
    Kjems, Lise
    Horn, Patrick
    [J]. HEPATOLOGY, 2021, 74 : 1164A - 1164A
  • [3] ODEVIXIBAT THERAPY IMPROVES CLINICALLY MEANINGFUL ENDPOINTS IN CHILDREN WITH PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS: DATA FROM THE PEDFIC 1 AND PEDFIC 2 TRIALS
    Thompson, Richard J.
    D'Antiga, Lorenzo
    Gonzales, Emmanuel
    Karpen, Saul J.
    Kjems, Lise
    Loomes, Kathleen
    Mack, Cara L.
    Ni, Quanhong
    Verkade, Henkjan J.
    Horn, Patrick
    [J]. GASTROENTEROLOGY, 2022, 162 (07) : S1296 - S1296
  • [4] EFFECTS ON SERUM BILE ACIDS, PRURITUS, AND SAFETY WITH UP TO 72 WEEKS OF ODEVIXIBAT TREATMENT: POOLED DATA FROM THE PEDFIC 1 AND PEDFIC 2 STUDIES IN CHILDREN WITH PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS
    Loomes, Kathleen M.
    Verkade, Henkjan J.
    Thompson, Richard J.
    Kamath, Binita
    Hardikar, Winita
    Lacaille, Florence
    Mozer-Glassberg, Yael
    Shteyer, Eyal
    Calvo, Pier Luigi
    Dalgic, Buket
    Grammatikopoulos, Tassos
    Rajwal, Sanjay
    Vittorio, Jennifer M.
    Soufi, Nisreen
    McKiernan, Patrick James
    Tessier, Mary Elizabeth
    Yu, Qifeng
    Kjems, Lise
    Horn, Patrick
    [J]. HEPATOLOGY, 2021, 74 : 1159A - 1160A
  • [5] Odevixibat therapy improves clinically meaningful end points in children with progressive familial intrahepatic cholestasis: Data from the PEDFIC 1 and PEDFIC 2 trials
    Thompson, Richard
    D'Antiga, Lorenzo
    Gonzales, Emmanuel
    Karpen, Saul
    Kjems, Lise
    Loomes, Kathleen
    Mack, Cara
    Ni, Quanhong
    Verkade, Henkjan
    Horn, Patrick
    [J]. JOURNAL OF HEPATOLOGY, 2021, 75 : S688 - S688
  • [6] NATIVE LIVER SURVIVAL IN ODEVIXIBAT SBA RESPONDERS: DATA FROM THE PEDFIC STUDIES IN PATIENTS WITH PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS
    Clemson, Christine
    Valcheva, Velichka
    Sturm, Ekkehard
    Verkade, Henkjan J.
    Thompson, Richard J.
    Ni, Quanhong
    Yu, Qifeng
    Mattsson, Jan P.
    [J]. HEPATOLOGY, 2022, 76 : S206 - S206
  • [7] EFFECT OF ODEVIXIBAT IN PATIENTS WITH PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS TYPE 2 WITH AT LEAST 1 SEVERE MUTATION (BSEP3 COMPOUND HETEROZYGOTES): POOLED DATA FROM THE PEDFIC 1 AND PEDFIC 2 STUDIES
    Verkade, Henkjan J.
    Thompson, Richard J.
    Sturm, Ekkehard
    Baumann, Ulrich
    Gonzales, Emmanuel M.
    D'Antiga, Lorenzo
    Valcheva, Velichka
    Ni, Quanhong
    Clemson, Christine
    [J]. HEPATOLOGY, 2022, 76 : S1548 - S1549
  • [8] Outcomes in adult patients with progressive familial intrahepatic cholestasis treated with odevixibat: subgroup analysis from the PEDFIC 2 study
    Roquelaure, Bertrand
    Verkade, Henkjan J.
    Loomes, Kathleen M.
    Stoll, Janis M.
    Clemson, Christine
    Gu, Tao
    Mattsson, Jan
    Stein, Philip
    [J]. JOURNAL OF HEPATOLOGY, 2023, 78 : S1003 - S1004
  • [9] LONG-TERM TREATMENT WITH ODEVIXIBAT IMPROVES MULTIPLE SLEEP PARAMETERS IN PATIENTS WITH PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS: A POOLED RESPONDER ANALYSIS FROM THE PHASE 3 PEDFIC STUDIES
    Thompson, Richard J.
    Calvo, Pier Luigi
    Hardikar, Winita
    Horn, Patrick
    Lainka, Elke
    Mack, Cara L.
    Ni, Quanhong
    Kjems, Lise
    [J]. GASTROENTEROLOGY, 2022, 162 (07) : S1297 - S1297
  • [10] NATIVE LIVER SURVIVAL IN ODEVIXIBAT SERUM BILE ACID RESPONDERS: DATA FROM PEDFIC STUDIES IN PATIENTS WITH PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS
    Jeanes, Yvonne
    Seamark, Leah
    Radcliffe, Olivia
    Gotto, James
    Watson, Bridie
    Trudgeon, Jenna
    Whiteman, Nicola
    Stockton, Elizabeth
    Apekey, Tanefa
    Colgan, Aisling
    Digby, Katie
    Hickson, Mary
    Williams, Marianne
    [J]. GUT, 2023, 72 (SUPPL_2) : A49 - A50
1234